申请人:Guangzhou Baiyunshan Pharmaceutical Holdings Co.,
Ltd. Baiyunshan Pharmaceutical General Factory
公开号:EP3950685A1
公开(公告)日:2022-02-09
Disclosed is a series of pyrazolopyridine compounds, and application thereof in the preparation of RET kinase inhibitors for treatment. Specifically disclosed is the compound represented by formula (I), or a pharmaceutically acceptable salt thereof.
本发明公开了一系列吡唑并吡啶化合物及其在制备治疗用 RET 激酶抑制剂中的应用。具体公开了式 (I) 所代表的化合物或其药学上可接受的盐。